Dominari Holdings (FRA:BP2A) EBIT per Share : €-3.68 (TTM As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Dominari Holdings EBIT per Share?

Dominari Holdings's EBIT per Share for the three months ended in Mar. 2024 was €-0.43. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €-3.68.

During the past 3 years, the average EBIT per Share Growth Rate was -1.70% per year. During the past 5 years, the average EBIT per Share Growth Rate was 43.90% per year. During the past 10 years, the average EBIT per Share Growth Rate was 54.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Dominari Holdings's EBIT per Share or its related term are showing as below:

FRA:BP2A' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -1.7 Med: 56.9 Max: 72.2
Current: -1.7

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Dominari Holdings was 72.20% per year. The lowest was -1.70% per year. And the median was 56.90% per year.

FRA:BP2A's 3-Year EBIT Growth Rate is ranked worse than
55.86% of 1305 companies
in the Biotechnology industry
Industry Median: 3.4 vs FRA:BP2A: -1.70

Dominari Holdings's EBIT for the three months ended in Mar. 2024 was €-2.58 Mil.

Dominari Holdings EBIT per Share Historical Data

The historical data trend for Dominari Holdings's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dominari Holdings EBIT per Share Chart

Dominari Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-34.57

-3.26

-1.72

-2.54

-3.82

Dominari Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															-0.68	-1.72	-0.54	-0.99	-0.43

Dominari Holdings EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Dominari Holdings's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-19.987	/	5.229
=	-3.82

Dominari Holdings's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-2.581	/	5.995
=	-0.43

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3.68

Dominari Holdings (FRA:BP2A) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Dominari Holdings EBIT per Share Related Terms

Thank you for viewing the detailed overview of Dominari Holdings's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Dominari Holdings (FRA:BP2A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dominari Holdings Inc (FRA:BP2A) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

DOMH:USA BP2A:Germany

Address

One Rockefeller Plaza, 11th Floor, New York, NY, USA, 10020

Website

https://www.dominariholdings.com

Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing a therapeutic drug pipeline through partnerships with educational institutions, including the University of Texas at Austin, the University of Maryland, Baltimore, and Wake Forest University. Its oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. The company is also developing an antiviral platform, in which the compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19.

Dominari Holdings (FRA:BP2A) Headlines

No Headlines